Pulmonary Function Testing (PFT) is a key tool in evaluating, diagnosing, and managing patients with respiratory diseases. However, interpreting the results can be challenging due to the numerous variables and complex physiological principles involved. This article aims to provide a comprehensive guide to PFT interpretation.
Spirometry is the cornerstone of PFT, measuring the volume and flow of air that can be inhaled and exhaled. Key parameters include Forced Vital Capacity (FVC), Forced Expiratory Volume in one second (FEV1), and the FEV1/FVC ratio. Abnormalities in these parameters can indicate obstructive or restrictive lung diseases.
Diffusing capacity of the lungs for carbon monoxide (DLCO) is an important measure of gas exchange. Reduced DLCO can indicate interstitial lung disease, emphysema, or pulmonary vascular disease. Adjustments for hemoglobin and alveolar volume are crucial for accurate interpretation.
Body plethysmography measures static lung volumes and airway resistance, providing additional information about lung mechanics. Elevated Residual Volume (RV) or Total Lung Capacity (TLC) can suggest air trapping or hyperinflation, while increased airway resistance may indicate bronchial hyperreactivity or obstruction.
Exercise testing can help identify exercise-induced bronchospasm, desaturation, or cardiovascular limitations. Parameters such as maximum voluntary ventilation (MVV) and oxygen consumption (VO2 max) are evaluated.
Interpreting PFTs is a complex task that requires a thorough understanding of respiratory physiology and pathology. Accurate interpretation is crucial for diagnosing and managing patients with respiratory diseases. As healthcare professionals, continuous learning and practice are key to mastering PFT interpretation.
1.
FDA Declines to Approve Achieve Life Sciences' Smoking-cessation Drug
2.
Uncovered biology underlies a novel drug used to treat triple-negative breast cancer.
3.
Chemotherapy damage to non-cancer cells may be the cause of breast cancer recurrence.
4.
Never in a million years did I think I'd have to limit my chemotherapy.
5.
Treating Depression: Crucial for Recovery From Fibromyalgia
1.
HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia
2.
Clinical Analysis of Prostate Cancer
3.
Sorafenib: Understanding the science behind a powerful cancer drug
4.
Early-Onset GI Cancers: Screening, AI Innovations & Research Advances 2025
5.
Comprehensive Breakthroughs in Oncology for Better Care
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
2.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
3.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
4.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation